The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:A $1.3B-AUM Startup's Fund Lineup Expands to Seven Not Rated 0.0 Email Routing List Email & Route  Print Print
Tuesday, June 08, 2021

A $1.3B-AUM Startup's Fund Lineup Expands to Seven

Reported by Neil Anderson, Managing Editor

The team at a three-year-old thematic ETF startup with $1.3 billion in AUM (as of March 31) has expanded their fund lineup to seven in recent weeks.

On Friday, Sylvia Jablonski, co-founder and chief investment officer of Defiance ETFs, LLC [profile], unveiled the launch of the Defiance Hotel, Airline, and Cruise ETF (ticker: CRUZ). A week earlier, the Defiance team, launched the Defiance Next Gen Altered Experience ETF (ticker: PSY). PSY is for investing in psychedelics-based medicine, while CRUZ is for investing in global travel.

"The travel reopening trade is here," Jablonski states.

Both new funds are advised by New York City-based Defiance and subadvised by Orinda, California-based Penserra Capital Management LLC, with Penserra's Dustin Lewellyn, Ernesto Tong, and Ananda Desai (managing director, managing director, and associate, respectively) as PMs. All the other service providers are the same for both, too (except for the index providers). Foreside Fund Services, LLC is the new funds' distributor, Cohen & Company, Ltd. is their independent accounting firm, U.S. Bancorp Fund Services LLC (dba U.S. Bank Global Fund Services is their transfer agent (and administrator and index receipt agent), U.S. Bank National Association is their custodian, and Morgan, Lewis & Bockius LLP provides legal counsel.

PSY, which comes with an expense ratio of 75 basis points, tracks the BITA Medical Psychedelics, Cannabis, and Ketamine Index from BITA GmbH. CRUZ, which comes with an expense ratio of 45 bps, tracks the BlueStar Global Hotels, Airlines, and Cruises Index from MV Index Solutions GmbH

Stay ahead of the news ... Sign up for our email alerts now

 Do You Recommend This Story?

Return to Top
 News Archives
2022: Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Add to My Yahoo!
follow us in feedly

  1. 2022 ICI Leadership Summit, May 25-26
  2. ALFI Roadshow to New York, May 25
  3. 2022 IDC Fund Directors Workshop, May 26
  4. Irish Funds Annual Global Funds Conference 2022, May 30-31
  5. WealthManagement Edge, May 31 - June 3
  6. MFDF 2022 Fund Governance and Regulatory Insights Conference, Jun 8-9
  7. 28th annual Expect Miracles East Coast Classic, June 9
  8. 2022 Sohn Investment Conference, June 9
  9. IDC webinar - Cybersecurity for Fund Boards: The Current Landscape, June 9
  10. MMI webinar - Driving Business Value with Artificial Intelligence & Data, June 15
  11. MFDF webinar - Key Takeaways From Morningstar's 2021 Annual Fund Fee Study, June 16
  12. MFDF Director Discussion Series - Open Forum (Chicago), June 21
  13. 2022 MMI Emerging Asset Managers Forum, June 23
  14. MFDF In Focus: Capitol Hill, A Conversation with Congressman Bryan Steil, June 28
  15. Financial Planning INVEST, Jun 28-29
  16. MFDF webinar - Differentiating Mutual-Fund-to-ETF Conversions, July 19
  17. MFDF Director Discussion Series - Open Forum (New York), July 20
  18. 2022 MMI Distribution Leadership Forum, Jul 20-21
  19. MFDF webinar - Fund Boards' Oversight of Investment Performance, July 28
  20. MFDF webinar - Performance, Perception and Manager Selection, September 14
  21. 2022 ICI Tax and Accounting Conference, Sep 18-21
  22. 5th annual Expect Miracles Atlantic Coast Classic, October 3
  23. Nicsa Fearless Leadership Symposium, Oct 6-7
  24. 2022 MMI Annual Conference, Oct 19-21
  25. 2022 IDC Fund Directors Conference, Oct 24-26
  26. 18th annual Expect Miracles Wine & Spirits Event, October 27

©All rights reserved to InvestmentWires, Inc. 1997-2022
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use